Tirzepatide for maintenance of bodyweight reduction in people with obesity in the USA (SURMOUNT-MAINTAIN): a multicentre, double-blind, randomised, placebo-controlled trial

The Lancet 2026

View at publisher
Authors: Deborah B. Horn, Louis J. Aronne, Sean Wharton, Harold Bays, Carel W. le Roux, Reshmi Srinath, Elisa Gomez-Valderas, Avigdor D. Arad, Sagar Das, Julia P Dunn, Anderson Ribeiro, Leonard C. Glass
+1 more Clare J. Lee
DOI: 10.1016/s0140-6736(26)00656-2
Cited by: 17
References: 28

Fields of Study & Subjects

Pharmacology and Obesity Treatment Bariatric Surgery and Outcomes Diet and metabolism studies

Publication details

Journal / source
The Lancet
Publisher
Elsevier BV
Volume
407
Issue
10545
Pages
2305–2318
Publication date
12 May 2026
Language
EN